Who AI recommends, and when it changes.
Data as of Apr 10, 2026 · Based on 21 AI answers · A buyer need in Healthcare AI Triage and Imaging Software. · See how Parse measures this
leads AI-powered pathology image analysis recommendations, with assistants frequently citing its TumorDetect tool on AISight for automated tumor detection and case prioritization. follows closely, offering FDA-cleared pan-cancer and prostate detection via deep learning. The field is fragmented, with specialized solutions for breast, lung, and custom workflows also recommended.
Where a different pick wins:
IbexIbex is specifically cited for clinical decision support in breast and prostate cancer diagnostics. · 1 source
Aiforia Create allows users to build their own AI models for detecting lymph node metastasis and other features. · 1 source
Paige PanCancer is highlighted for its robust detection of both common and rare cancers with high AUC. · 1 source
MindPeakMindpeak’s tools automatically score tissue images and count cell types, used for breast and lung IHC diagnostics. · 2 sources
Recommendation share
PathAI leads at 19% of AI recommendations; Paige.ai follows at 14%.
By platform
Platforms disagree: PathAI leads on Google AI Overviews, Paige Prostate Detect on ChatGPT.
Representative prompts behind this market ranking, and how AI tends to answer.
Buyer needs that sit next to this one in the same market.
Why here: Automates tumor assessment with TumorDetect on AISight, cited for workflow efficiency and case prioritization. · 2 sources
Why here: FDA-cleared AI for pan-cancer and prostate detection, using deep learning to highlight suspicious areas. · 2 sources
Why here: Cloud-based AI for analyzing large tissue images, improving speed and accuracy in cancer detection. · 2 sources
Why here: Automated tumor identification and cell scoring for histology, often highlighted for breast and lung diagnostics. · 2 sources
Why here: Enables custom AI model creation for detecting lymph node metastasis and other features. · 1 source
Why here: Pre-trained models like Pan-Cancer H&E and Breast H&E Cancer Cell Phenotyper for tumor detection. · 1 source
Why here: Clinical decision support for breast and prostate cancer diagnostics, cited in pathology workflow examples. · 1 source
Why here: Clinically validated for prostate and breast cancer, mentioned alongside PathAI and Paige.ai in overviews. · 1 source
Why here: FDA-cleared pan-cancer detection that identifies suspicious areas to assist pathologists. · 1 source
Why here: Highly robust pan-cancer detection with high specimen-level AUC for common and rare cancers. · 1 source
Why here: AI-powered software for prostate cancer detection in whole-slide images, with FDA authorization. · 1 source
“I am looking for a pathology image analysis software that uses AI to detect cancer cells.”
AI assistants list several specialized platforms, with 
